Adjust Sertraline, Not Adderall
The bruising is most likely caused by sertraline and you should consider reducing the dose or switching to an alternative antidepressant with less bleeding risk, such as escitalopram or an SNRI like venlafaxine. Adderall is not associated with bruising or bleeding complications.
Why Sertraline is the Culprit
Sertraline, like all SSRIs, can cause abnormal bleeding including ecchymosis (bruising), hematoma, epistaxis, petechiae, and hemorrhage 1. This occurs because SSRIs block serotonin reuptake in platelets, depleting platelet serotonin stores and impairing platelet aggregation—the mechanism that normally helps blood clot 2. The FDA drug label for sertraline explicitly warns about this bleeding risk 3.
The guideline evidence is clear: abnormal bleeding can occur with SSRIs, especially when combined with other medications that affect coagulation 1. While your patient isn't on NSAIDs or aspirin (which would dramatically increase risk), the SSRI alone can cause this problem.
Adderall's Role (or Lack Thereof)
Adderall (amphetamine/dextroamphetamine) does not cause bruising or bleeding disorders. The FDA label for Adderall lists common side effects as stomachache, decreased appetite, and nervousness—no hematologic effects 4. The main concern with combining Adderall and sertraline is serotonin syndrome risk, as both are serotonergic agents 1, 4, but this presents with agitation, confusion, tremors, and autonomic instability—not bruising.
Clinical Action Plan
Immediate Assessment
- Check complete blood count, platelet count, PT/PTT, and bleeding time
- Ask specifically about other bleeding symptoms: nosebleeds, gum bleeding, prolonged bleeding from minor cuts, heavy menstrual bleeding
- Review for any NSAIDs, aspirin, or anticoagulants the patient may be taking (including over-the-counter)
Medication Adjustment Strategy
Option 1 (Preferred if anxiety is well-controlled):
- Reduce sertraline dose by 25-50% and monitor for both bleeding resolution and anxiety symptom stability
- If bruising resolves but anxiety worsens, proceed to Option 2
Option 2 (Switch SSRI):
- Transition to escitalopram or citalopram, which have the least effect on CYP450 enzymes and may have lower propensity for drug interactions 1
- Use cross-taper method: start new SSRI at low dose while gradually reducing sertraline over 1-2 weeks to avoid discontinuation syndrome 1
Option 3 (Switch to SNRI):
- Consider duloxetine or venlafaxine if SSRI alternatives fail 1
- SNRIs also carry bleeding risk but may be better tolerated in some patients
- Note: Venlafaxine requires blood pressure monitoring 1
Critical Pitfalls to Avoid
Don't abruptly stop sertraline: This causes discontinuation syndrome (dizziness, nausea, paresthesias, anxiety) 1. Taper over 1-2 weeks minimum.
Don't assume it's just trauma: Even if bruising seems proportionate to minor bumps, SSRIs lower the threshold for bruising 2, 5.
Don't discontinue Adderall: This would destabilize whatever condition it's treating (likely ADHD) without addressing the actual problem.
Monitor for serotonin syndrome during any transition: When switching between serotonergic agents, watch for mental status changes, neuromuscular hyperactivity, and autonomic instability in the first 24-48 hours after dose changes 1.
Why Not Just Continue Both?
While the bleeding risk with SSRIs is generally low and usually involves minor events 5, continuing sertraline with active bruising puts the patient at risk for more serious bleeding complications, particularly if they later need to take NSAIDs for pain or develop another condition requiring anticoagulation. The evidence shows this is a real, medication-induced adverse effect that warrants intervention 2, 5.